Apellis Pharmaceuticals · 6 hours ago
Associate Director, Program Management
Waltham, MA
Full-time
Onsite
Lead/Staff, Director/Executive
$175K/yr - $262K/yr
10+ years expApellis Pharmaceuticals is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. The Pipeline PM is responsible for overseeing the planning, execution, and monitoring of all Pipeline Key Initiatives/pre-clinical programs within the Strategy Team, ensuring alignment with overall business objectives by managing budgets, timelines, resources, risks, and communication to achieve successful outcomes.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Work with Pipeline Strategy Lead to define Pipeline strategy, Key Initiatives for near-term value-drivers, goals, scope, and deliverables, aligning them with corporate strategy
Drive weekly Pipeline Strategy Team and Discovery Early Asset Team meetings including agenda creation, meeting management and minutes
Drive alliance management with partners in Discovery including contract updates and conflict resolution
Co-develops strategy Pipeline strategy, working directly with VPs and ED, PMO
Support Strategy Lead in creation of Board of Directors presentations and facilitate EC Quarterly Business Reviews
Monitor individual Key Initiative progress, identifying potential issues, and coordinating necessary adjustments across projects within the program
Manage budget and timelines effectively across different projects within the program
Support ad hoc sub-team projects related to the Pipeline as needed
Identifying potential risks, developing mitigation strategies, and proactively addressing issues that could impact program success
Maintain clear communication with key stakeholders, including manager, program and project teams, senior leadership, clients, and internal departments, ensuring alignment and buy-in
Regularly monitor progress against program goals, generate reports, and identify areas for improvement
Adapt to changing requirements and effectively managing transitions within the program
Ensure program deliverables meet quality standards and adhere to established processes
Work alongside other PMs to ensure consistency across all Early Asset Teams
Qualification
Required
Minimum of 10 years industry experience in program or operational management, with responsibilities for pre-clinical, clinical or commercial stage collaborations
Bachelor's degree required
Track record of having managed successful programs or projects
Understanding of the drug development process and working knowledge of the essential activities for all key functional areas
Ability to work cross-functionally and facilitate decision-making between different departments
Strong communicator with the ability to work with scientific and commercial team members at all levels
Collegiate team player that has a customer service approach and is solution-oriented
Solid presentation and excellent interpersonal skills
Innovative and flexible to adapt to the dynamic needs of a fast-growing biotech company
Preferred
Prior experience in small Biotech or large Pharma environments
Benefits
401(k) plan with company match
Inclusive family building benefits
Flexible time off
Summer and winter shutdowns
Paid family leave
Disability and life insurance
Company
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
501-1000 employees
H1B Sponsorship
Apellis Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (6)
2023 (6)
2022 (8)
2021 (7)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$919.6MKey Investors
Swedish Orphan BiovitrumSixth StreetNorthern Star Partners
2025-06-01Post Ipo Debt· $275M
2024-05-14Post Ipo Debt· $475M
2022-04-14Post Ipo Equity· $1.07M
Leadership Team
Cedric Francois
Co-Founder and CEO
Caroline Baumal
Chief Medical Officer
Recent News
Investor's Business Daily
2026-01-13
Company data provided by crunchbase